Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.

MLA

Raoul, Jean-Luc, et al. “Relationship between Baseline Hepatic Status and Outcome, and Effect of Sorafenib on Liver Function: SHARP Trial Subanalyses.” Journal of Hepatology, vol. 56, no. 5, May 2012, pp. 1080–88. EBSCOhost, https://doi.org/10.1016/j.jhep.2011.12.009.

APA

Raoul, J.-L., Bruix, J., Greten, T. F., Sherman, M., Mazzaferro, V., Hilgard, P., Scherubl, H., Scheulen, M. E., Germanidis, G., Dominguez, S., Ricci, S., Nadel, A., Moscovici, M., Voliotis, D., & Llovet, J. M. (2012). Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses. Journal of Hepatology, 56(5), 1080–1088. https://doi.org/10.1016/j.jhep.2011.12.009

Chicago

Raoul, Jean-Luc, Jordi Bruix, Tim F Greten, Morris Sherman, Vincenzo Mazzaferro, Philip Hilgard, Hans Scherubl, et al. 2012. “Relationship between Baseline Hepatic Status and Outcome, and Effect of Sorafenib on Liver Function: SHARP Trial Subanalyses.” Journal of Hepatology 56 (5): 1080–88. doi:10.1016/j.jhep.2011.12.009.